Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$26.69M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
266.73%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$24.64M
Q3 2024
Cash
Q3 2024
P/E
-0.1397
Nov 29, 2024 EST
Free Cash Flow
-$14.93M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.160M $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $870.0K $510.0K $400.0K $350.0K $500.0K $510.0K $0.00 $0.00 $0.00
YoY Change -100.0% 3060.0% -100.0% -98.85% 70.59% 27.5% 14.29% -30.0% -1.96%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.160M $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $870.0K $510.0K $400.0K $350.0K $500.0K $510.0K $0.00 $0.00 $0.00
Cost Of Revenue $470.0K $130.0K
Gross Profit $2.700M -$20.00K
Gross Profit Margin 85.44% -20.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Selling, General & Admin $6.420M $7.560M $6.474M $5.029M $4.580M $5.727M $7.467M $10.14M $8.074M $6.013M $4.530M $3.510M $1.670M $2.700M $2.580M $2.680M $3.810M $1.440M $20.00K $0.00 $0.00 $4.480M $4.550M $2.820M $2.280M $3.040M $4.630M $3.830M $2.980M $2.390M $230.0K
YoY Change -15.08% 16.77% 28.73% 9.8% -20.03% -23.3% -26.38% 25.63% 34.28% 32.74% 29.06% 110.18% -38.15% 4.65% -3.73% -29.66% 164.58% 7100.0% -100.0% -1.54% 61.35% 23.68% -25.0% -34.34% 20.89% 28.52% 24.69% 939.13% 35.29%
% of Gross Profit 100.0%
Research & Development $14.31M $11.72M $7.800M $5.131M $11.08M $11.84M $18.78M $29.11M $32.91M $14.49M $6.507M $12.29M $3.860M $1.580M $1.200M $4.640M $6.330M $2.670M $950.0K $0.00 $3.620M $6.000M $3.750M $3.420M $2.350M $3.730M $3.840M $4.420M $3.990M $2.130M
YoY Change 22.08% 50.29% 52.02% -53.7% -6.43% -36.95% -35.47% -11.54% 127.11% 122.67% -47.04% 218.32% 144.3% 31.67% -74.14% -26.7% 137.08% 181.05% -100.0% -39.67% 60.0% 9.65% 45.53% -37.0% -2.86% -13.12% 10.78% 87.32% 88.5%
% of Gross Profit 58.52%
Depreciation & Amortization $135.0K $85.00K $87.00K $201.0K $240.0K $272.0K $245.0K $157.0K $72.00K $20.00K $43.00K $63.00K $140.0K $360.0K $380.0K $410.0K $200.0K $30.00K $0.00 $0.00 $30.00K $150.0K $130.0K $120.0K $90.00K $70.00K $90.00K $70.00K $50.00K $40.00K $60.00K
YoY Change 58.82% -2.3% -56.72% -16.25% -11.76% 11.02% 56.05% 118.06% 260.0% -53.49% -31.75% -55.0% -61.11% -5.26% -7.32% 105.0% 566.67% -100.0% -80.0% 15.38% 8.33% 33.33% 28.57% -22.22% 28.57% 40.0% 25.0% -33.33% 200.0%
% of Gross Profit 13.33%
Operating Expenses $21.43M $21.58M $14.27M $10.16M $15.66M $17.57M $26.25M $39.25M $40.98M $20.50M $12.34M $17.30M $5.530M $4.280M $3.780M $7.320M $10.14M $4.110M $20.00K $0.00 $0.00 $8.100M $10.55M $6.570M $5.700M $5.390M $8.360M $7.670M $7.400M $6.380M $3.930M
YoY Change -0.7% 51.19% 40.49% -35.13% -10.86% -33.07% -33.12% -4.22% 99.88% 66.16% -28.67% 212.82% 29.21% 13.23% -48.36% -27.81% 146.72% 20450.0% -100.0% -23.22% 60.58% 15.26% 5.75% -35.53% 9.0% 3.65% 15.99% 62.34% 101.54%
Operating Profit -$21.43M -$21.58M -$14.27M -$10.16M -$17.57M -$26.25M -$39.25M -$40.98M -$20.50M -$12.34M -$17.30M -$1.580M -$3.800M
YoY Change -0.7% 51.19% 40.49% -33.07% -33.12% -4.22% 99.88% 66.16% -28.67% -58.42%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Interest Expense $1.442M $470.0K $6.000K $44.00K $283.0K $67.00K $21.00K $37.00K $6.000K $3.000K $30.00K $30.00K -$230.0K -$10.00K -$10.00K $110.0K $250.0K $20.00K $0.00 $0.00 $0.00 -$520.0K $200.0K $300.0K $2.920M -$190.0K $20.00K $150.0K $20.00K $60.00K $50.00K
YoY Change 206.81% 7733.33% -86.36% -84.45% 322.39% 219.05% -43.24% 516.67% 100.0% -90.0% 0.0% -113.04% 2200.0% 0.0% -109.09% -56.0% 1150.0% -100.0% -360.0% -33.33% -89.73% -1636.84% -1050.0% -86.67% 650.0% -66.67% 20.0% -600.0%
% of Operating Profit
Other Income/Expense, Net $1.442M $471.0K $6.000K $44.00K $0.00 $4.150M $10.76M $11.45M -$3.805M $718.0K $21.00K $15.00K -$1.470M $0.00 -$10.00K $0.00
YoY Change 206.16% 7750.0% -86.36% -100.0% -61.43% -6.03% -400.89% -629.94% 3319.05% 40.0% -101.02% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Pretax Income -$19.99M -$21.11M -$14.27M -$10.12M -$15.38M -$13.42M -$15.49M -$27.80M -$44.79M -$19.78M -$12.34M -$17.30M -$7.630M -$1.710M -$3.730M -$7.210M -$9.890M -$4.100M -$20.00K $0.00 $0.00 -$8.620M -$9.480M -$5.760M -$17.39M -$18.56M -$9.490M -$7.010M -$7.390M -$6.320M -$3.880M
YoY Change -5.31% 47.95% 41.04% -34.23% 14.6% -13.37% -44.28% -37.92% 126.37% 60.34% -28.67% 126.72% 346.2% -54.16% -48.27% -27.1% 141.22% 20400.0% -100.0% -9.07% 64.58% -66.88% -6.3% 95.57% 35.38% -5.14% 16.93% 62.89% 98.97%
Income Tax -$1.640M -$1.425M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.35M -$19.69M -$14.27M -$10.04M -$15.30M -$13.37M -$15.17M -$27.26M -$43.74M -$19.78M -$12.32M -$17.07M -$8.150M -$1.710M -$3.730M -$7.210M -$9.890M -$4.100M -$20.00K $0.00 $15.36M -$8.620M -$9.480M -$5.760M -$17.39M -$18.56M -$9.490M -$7.010M -$7.390M -$6.320M -$3.880M
YoY Change -6.79% 37.98% 42.06% -34.37% 14.48% -11.91% -44.33% -37.68% 121.07% 60.62% -27.84% 109.42% 376.61% -54.16% -48.27% -27.1% 141.22% 20400.0% -100.0% -278.19% -9.07% 64.58% -66.88% -6.3% 95.57% 35.38% -5.14% 16.93% 62.89% 98.97%
Net Earnings / Revenue -54.11% -3730.0% -86200.0% -1089.66% -1129.41% -4347.5% -5302.86% -1898.0% -1374.51%
Basic Earnings Per Share -$1.14 -$1.31 -$0.19 -$0.66
Diluted Earnings Per Share -$1.14 -$1.31 -$0.19 -$0.66 -$9.309M -$21.45M -$42.71M -$101.2M -$18.97M -$11.18M -$9.477M -$17.07M -$10.32M -$2.672M -$6.115M -$12.22M -$19.78M -$45.56M -$2.000M $0.00 -$542.6M -$9.795B -$10.48B -$5.411B -$16.76B -$22.25B -$20.98B -$17.03B -$23.69B -$25.15B -$19.68B

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Cash & Short-Term Investments $23.18M $41.79M $67.33M $6.227M $15.05M $28.92M $17.12M $19.06M $20.82M $17.53M $14.63M $9.950M $6.680M $2.650M $2.720M $5.860M $11.49M $12.19M $0.00 $0.00 $0.00 $330.0K $860.0K $3.370M $4.390M $2.580M $390.0K $2.440M $1.860M $80.00K $1.680M
YoY Change -44.54% -37.93% 981.18% -58.61% -47.97% 68.95% -10.18% -8.47% 18.79% 19.79% 47.04% 48.95% 152.08% -2.57% -53.58% -49.0% -5.74% -100.0% -61.63% -74.48% -23.23% 70.16% 561.54% -84.02% 31.18% 2225.0% -95.24%
Cash & Equivalents $23.18M $41.79M $67.33M $6.227M $15.05M $28.92M $17.12M $19.06M $20.82M $17.53M $14.63M $9.950M $330.0K $860.0K $3.040M $3.870M $2.460M $390.0K $1.980M
Short-Term Investments $0.00 $330.0K $520.0K $130.0K $0.00 $460.0K $0.00 $0.00 $0.00
Other Short-Term Assets $2.286M $3.500M $1.533M $1.238M $1.378M $593.0K $827.0K $2.515M $9.519M $1.548M $1.590M $2.490M $40.00K $20.00K $10.00K $80.00K $60.00K $30.00K $0.00 $0.00 $0.00 $160.0K $90.00K $300.0K $150.0K $40.00K $50.00K $40.00K $150.0K $70.00K $50.00K
YoY Change -34.69% 128.31% 23.83% -10.16% 132.38% -28.3% -67.12% -73.58% 514.92% -2.64% -36.14% 6125.0% 100.0% 100.0% -87.5% 33.33% 100.0% -100.0% 77.78% -70.0% 100.0% 275.0% -20.0% 25.0% -73.33% 114.29% 40.0%
Inventory $0.00 $0.00 $350.0K $430.0K $240.0K
Prepaid Expenses
Receivables $0.00 $410.0K $340.0K $30.00K $0.00 $0.00 $0.00 $0.00
Other Receivables $20.00K $0.00 $320.0K $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $27.40M $45.52M $68.86M $7.934M $16.43M $29.51M $17.94M $21.57M $30.34M $19.07M $16.22M $12.46M $7.120M $3.330M $2.750M $5.930M $11.56M $12.22M $0.00 $0.00 $0.00 $840.0K $1.370M $4.910M $4.540M $2.620M $520.0K $2.490M $2.020M $150.0K $1.730M
YoY Change -39.8% -33.89% 767.89% -51.7% -44.34% 64.47% -16.82% -28.9% 59.06% 17.59% 30.18% 75.0% 113.81% 21.09% -53.63% -48.7% -5.4% -100.0% -38.69% -72.1% 8.15% 73.28% 403.85% -79.12% 23.27% 1246.67% -91.33%
Property, Plant & Equipment $21.94M $20.69M $1.484M $453.0K $786.0K $607.0K $872.0K $905.0K $494.0K $65.00K $40.00K $220.0K $320.0K $510.0K $1.050M $1.450M $2.060M $300.0K $220.0K $350.0K $270.0K $290.0K $240.0K $140.0K $170.0K $120.0K $150.0K $0.00
YoY Change 6.02% 1294.2% 227.59% -42.37% 29.49% -30.39% -3.65% 83.2% 660.0% 62.5% -81.82% -31.25% -37.25% -51.43% -27.59% -29.61% 586.67% -37.14% 29.63% -6.9% 20.83% 71.43% -17.65% 41.67% -20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $180.0K $120.0K $23.00K $23.00K $23.00K $23.00K $23.00K $23.00K $14.00K $6.000K $0.00 $40.00K $30.00K $90.00K $90.00K $10.00K $10.00K $0.00 $0.00 $10.00K $30.00K $20.00K $20.00K $0.00 $30.00K $120.0K $80.00K $80.00K $100.0K
YoY Change 50.0% 421.74% 0.0% 0.0% 0.0% 0.0% 0.0% 64.29% 133.33% -100.0% 33.33% -66.67% 0.0% 800.0% 0.0% -100.0% -66.67% 50.0% 0.0% -100.0% -75.0% 50.0% 0.0% -20.0%
Total Long-Term Assets $27.82M $26.34M $1.507M $476.0K $809.0K $630.0K $895.0K $928.0K $508.0K $71.00K $40.00K $960.0K $360.0K $780.0K $1.330M $1.450M $2.070M $300.0K $0.00 $0.00 $0.00 $670.0K $690.0K $540.0K $510.0K $240.0K $170.0K $280.0K $200.0K $220.0K $110.0K
YoY Change 5.6% 1647.84% 216.6% -41.16% 28.41% -29.61% -3.56% 82.68% 615.49% 77.5% -95.83% 166.67% -53.85% -41.35% -8.28% -29.95% 590.0% -100.0% -2.9% 27.78% 5.88% 112.5% 41.18% -39.29% 40.0% -9.09% 100.0%
Total Assets $55.22M $71.86M $70.37M $8.410M $17.24M $30.14M $18.84M $22.50M $30.85M $19.14M $16.26M $13.42M $7.480M $4.110M $4.080M $7.380M $13.63M $12.52M $0.00 $0.00 $0.00 $1.510M $2.060M $5.450M $5.050M $2.860M $690.0K $2.770M $2.220M $370.0K $1.840M
YoY Change
Accounts Payable $770.0K $920.0K $524.0K $886.0K $2.315M $1.034M $2.020M $1.993M $4.413M $996.0K $140.0K $400.0K $390.0K $270.0K $400.0K $580.0K $730.0K $540.0K $0.00 $0.00 $0.00 $2.600M $860.0K $790.0K $770.0K $620.0K $890.0K $450.0K $110.0K $580.0K $160.0K
YoY Change -16.3% 75.57% -40.86% -61.73% 123.89% -48.81% 1.35% -54.84% 343.07% 611.43% -65.0% 2.56% 44.44% -32.5% -31.03% -20.55% 35.19% -100.0% 202.33% 8.86% 2.6% 24.19% -30.34% 97.78% 309.09% -81.03% 262.5%
Accrued Expenses $4.999M $3.120M $3.030M $2.080M $2.960M $2.251M $3.600M $2.940M $574.0K $1.836M $890.0K $0.00 $30.00K $210.0K $10.00K $50.00K $60.00K $190.0K $0.00 $0.00 $0.00 $450.0K $440.0K $440.0K $0.00 $90.00K $0.00 $0.00
YoY Change 60.22% 2.97% 45.67% -29.73% 31.5% -37.47% 22.45% 412.2% -68.74% 106.29% -100.0% -85.71% 2000.0% -80.0% -16.67% -68.42% -100.0% 2.27% 0.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $900.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $63.00K $60.00K $20.00K $20.00K $0.00 $0.00 $1.980M $4.000M $0.00 $0.00 $20.00K $0.00 $0.00 $0.00
YoY Change 5.0% 0.0% -100.0% -50.5% -100.0%
Total Short-Term Liabilities $6.738M $7.060M $3.554M $2.966M $5.275M $3.384M $9.793M $19.76M $15.58M $9.588M $1.030M $400.0K $420.0K $500.0K $430.0K $620.0K $1.690M $730.0K $10.00K $0.00 $0.00 $5.020M $5.530M $1.470M $1.200M $1.170M $1.360M $1.050M $430.0K $950.0K $160.0K
YoY Change -4.56% 98.65% 19.82% -43.77% 55.88% -65.44% -50.43% 26.85% 62.44% 830.87% 157.5% -4.76% -16.0% 16.28% -30.65% -63.31% 131.51% 7200.0% -100.0% -9.22% 276.19% 22.5% 2.56% -13.97% 29.52% 144.19% -54.74% 493.75%
Long-Term Debt $162.0K $220.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.50M $5.000M $2.000M $2.000M $1.000M $1.550M $30.00K $0.00 $0.00 $0.00
YoY Change -26.36% -100.0% -100.0% 110.0% 150.0% 0.0% 100.0% -35.48% 5066.67%
Other Long-Term Liabilities $8.622M $8.400M $1.403M $186.0K $473.0K $302.0K $402.0K $492.0K $267.0K $0.00 $0.00 $30.00K $90.00K $0.00 $1.380M $610.0K $2.390M $1.180M $40.00K $30.00K $0.00 $0.00 $0.00 $0.00
YoY Change 2.64% 498.72% 654.3% -60.68% 56.62% -24.88% -18.29% 84.27% -100.0% -66.67% 126.23% -74.48% 102.54% 2850.0% 33.33%
Total Long-Term Liabilities $8.784M $8.620M $1.403M $186.0K $473.0K $302.0K $402.0K $492.0K $267.0K $0.00 $0.00 $0.00 $0.00 $30.00K $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $11.88M $5.610M $4.390M $3.180M $1.040M $1.580M $30.00K $0.00 $0.00 $0.00
YoY Change 1.9% 514.4% 654.3% -60.68% 56.62% -24.88% -18.29% 84.27% -100.0% -70.0% -100.0% 111.76% 27.79% 38.05% 205.77% -34.18% 5166.67%
Total Liabilities $15.52M $17.30M $4.957M $379.0K $2.870M $777.0K $8.281M $18.65M $14.79M $9.588M $1.030M $400.0K $420.0K $530.0K $530.0K $620.0K $1.690M $730.0K $10.00K $0.00 $0.00 $16.90M $11.14M $5.870M $4.380M $2.210M $2.940M $1.080M $430.0K $950.0K $160.0K
YoY Change -10.28% 249.0% 1207.92% -86.79% 269.37% -90.62% -55.6% 26.08% 54.3% 830.87% 157.5% -4.76% -20.75% 0.0% -14.52% -63.31% 131.51% 7200.0% -100.0% 51.71% 89.78% 34.02% 98.19% -24.83% 172.22% 151.16% -54.74% 493.75%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Basic Shares Outstanding 16.11M 15.33M 121.9M 19.01M
Diluted Shares Outstanding 16.11M 15.33M 121.9M 19.01M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.7285 Million

About Theriva Biologics, Inc.

Theriva Biologics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland and currently employs 21 full-time employees. Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. The company is advancing a new oncolytic adenovirus platform. Its candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01 is an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment. SYN-004 (ribaxamase) is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome damage. SYN-020 is a recombinant oral formulation of the enzyme intestinal alkaline phosphatase produced under current good manufacturing practice conditions and intended to treat both local GI and systemic diseases. Its research programs include VCN-11 Albumin Shield Technology and SYN-006, SYN-007, other oncolytic virus.

Industry: Pharmaceutical Preparations Peers: ABEONA THERAPEUTICS INC. ATHERSYS, INC / NEW Cabaletta Bio, Inc. HUMANIGEN, INC YIELD10 BIOSCIENCE, INC. NexImmune, Inc. KINETA, INC./DE RenovoRx, Inc. Sigilon Therapeutics, Inc.